Skip to main content
NORTHEAST PHARMACEUTICAL GROUP CO.,LTD logo

NORTHEAST PHARMACEUTICAL GROUP CO.,LTD — Investor Relations & Filings

Ticker · 000597 ISIN · CNE0000009G0 LEI · 300300HX6JTMOEENF158 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,606 across all filing types
Latest filing 2023-08-22 AGM Information
Country CN China
Listing Shenzhen Stock Exchange 000597

About NORTHEAST PHARMACEUTICAL GROUP CO.,LTD

https://www.nepharm.com.cn

Northeast Pharmaceutical Group Co., Ltd. (NEPG) specializes in the research, development, manufacture, and distribution of active pharmaceutical ingredients (APIs) and finished dosage forms. The company operates as a large-scale integrated pharmaceutical enterprise with a diverse product portfolio encompassing vitamins, antibiotics, cardiovascular agents, and digestive system medications. NEPG is recognized as a global leader in the production of Vitamin C and Vitamin B1, alongside significant output in caffeine and fosfomycin. Its manufacturing facilities adhere to international quality standards, including Good Manufacturing Practice (GMP) certifications. The company serves a broad international market, exporting products to numerous countries while maintaining a strong domestic presence. NEPG focuses on technological innovation and industrial scaling to provide high-quality chemical raw materials and pharmaceutical preparations for global healthcare needs.

Recent filings

Filing Released Lang Actions
关于召开公司2023年第二次临时股东大会的通知
AGM Information Classification · 95% confidence The document is a notice about convening the company's 2023 second extraordinary general meeting of shareholders, detailing the meeting date, voting procedures, proposals to be voted on, and instructions for shareholders. It does not contain financial statements or results, but rather is an announcement of a shareholder meeting and related procedural information. The document length is under 5,000 characters and it serves as a meeting notice rather than the meeting materials or results. Therefore, it fits the category of AGM Information (AGM-R) as it relates to the Annual/Extraordinary General Meeting information and materials shared for that meeting.
2023-08-22 Chinese
独立董事关于控股股东及其他关联方占用公司资金、公司对外担保情况的专项说明和独立意见
Audit Report / Information Classification · 95% confidence The document is a special statement and independent opinion by the independent directors of Northeast Pharmaceutical Group Co., Ltd. regarding the use of company funds by controlling shareholders and related parties, as well as the company's external guarantees for the half-year period ending June 30, 2023. It references regulatory rules and the company's articles of association. The content is a formal independent directors' report on specific financial and governance matters, not a full annual or interim report, nor an announcement of voting results or management changes. It is a standalone audit-related opinion on specific financial interactions and guarantees, fitting the definition of an Audit Report / Information (AR). The document length is short but contains substantive content, not merely an announcement or certification. Therefore, the classification is AR with high confidence. H1 2023
2023-08-22 Chinese
关于补选第九届董事会非独立董事的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the election of a non-independent director to the company's board. It discusses the nomination and approval process for a board member and mentions the governance structure. There is no financial data, no mention of annual or quarterly reports, no audit information, and no shareholder voting results. The content clearly relates to changes in the company's board of directors. Therefore, the document fits the category of Board/Management Information (MANG). The document length is short and focused on management changes, not a report or announcement of a report publication.
2023-08-22 Chinese
独立董事关于补选第九届董事会非独立董事的议案发表的独立意见
Board/Management Information Classification · 95% confidence The document is a statement of independent directors expressing their opinion on the proposal to elect a non-independent director to the ninth board of directors. It references compliance with stock exchange listing rules, company articles, and relevant laws. The content is about board/management changes and the approval process for a director candidate. The document length is short (514 characters), but it contains substantive content related to board matters, not just an announcement or notice. Therefore, it fits best under Board/Management Information (MANG).
2023-08-22 Chinese
北京德恒律师事务所关于东北制药集团股份有限公司2023年第一次临时股东大会的法律意见
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion issued by a law firm regarding the legality and procedural compliance of a company's 2023 first extraordinary general meeting (临时股东大会). It details the convening, attendance, voting procedures, and results of the shareholders' meeting. The document does not contain financial statements or financial performance data but focuses on the legal validation of the meeting process and voting outcomes. This type of document is typically classified as a Declaration of Voting Results & Voting Rights Announcements (DVA), as it officially reports the voting results and confirms the legitimacy of the shareholder meeting procedures.
2023-08-10 Chinese
关于回购注销部分限制性股票减少注册资本暨通知债权人的公告
Share Issue/Capital Change Classification · 95% confidence The document is an official announcement from a company regarding the repurchase and cancellation of restricted shares, which leads to a reduction in registered capital. It includes details about the board and shareholder meetings approving the repurchase, the number of shares involved, and a notification to creditors about their rights following the capital reduction. The document does not contain financial statements or detailed financial data but is a formal notice about a capital change event. This fits the category of a Share Issue/Capital Change announcement rather than a full financial report or other types of filings.
2023-08-10 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.